| Business Summary | | Biogen,
Inc.
is
a
biopharmaceutical
company
principally
engaged
in
the
business
of
developing,
manufacturing
and
marketing
drugs
for
human
healthcare.
Biogen
currently
derives
revenues
from
sales
of
its
Avonex
(Interferon
beta-1a)
product
for
the
treatment
of
relapsing
forms
of
multiple
sclerosis,
and
from
royalties
on
worldwide
sales
by
the
Company's
licensees
of
a
number
of
products
covered
under
patents
controlled
by
the
Company.
Such
products
include
certain
forms
of
alpha
interferon,
hepatitis
B
vaccines
and
hepatitis
B
diagnostic
test
kits,
among
others.
Biogen
continues
to
have
an
active
development
program
related
to
Avonex,
and
is
conducting
several
important
clinical
trials
of
the
product.
Biogen
also
continues
to
devote
significant
resources
to
its
other
ongoing
development
efforts. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | BGEN
is
a
biopharmaceutical
company
primarily
engaged
in
the
business
of
developing,
manufacturing
and
marketing
drugs
for
human
health
care.
BGEN
currently
derives
revenues
from
sales
of
AVONEX
and
from
royalties
on
worldwide
sales
by
licensees.
For
the
six
months
ended
6/01,
total
revenues
rose
11%
to
$497.7
million.
Net
income
decreased
26%
to
$144
million.
Results
reflect
an
increase
in
the
sales
volume
of
AVONEX,
offset
by
decreased
gains
on
securities. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| James Vincent, 61 Chairman | $1.5M | $36.2M | James Mullen, 42 Pres,
CEO, Chief Operating Officer, Director | 1.0M | 7.7M | David Buckley Exec.
VP, Technical Operations | -- | -- | Sylvie Gregoire Exec.
VP, Technical Operations | -- | -- | Hans-Peter Hasler Exec.
VP, Commercial Operations | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|